Loews 10-Q 2026-09-30
L · CIK 60086 · Form 10-Q · Period ended September 30, 2026 · Filed November 2, 2026
Revenue rose 1.9% to $4.76 billion. Net income was $306 million.
8 sections, 328K characters. Original on sec.gov · ·
| Measure | Quarter ended Sep 30, 2026 | Quarter ended Sep 30, 2025 | Change |
|---|---|---|---|
| Revenue | $4.76B | $4.67B | +1.9% |
| Net income | $306M | $504M | -39.3% |
| Diluted EPS | $1.50 | $2.43 | -38.3% |
From the XBRL facts tagged to this filing; both columns are as reported in this filing.
Cover and table of contents
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended September 30, 2026
OR
☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
For the Transition Period From ____________ to _____________
Commission File Number 1-06541
LOEWS CORPORATION
(Exact name of registrant as specified in its charter)
| Delaware | 13-2646102 | ||||
| (State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) |
9 West 57****th Street, New York, NY 10019-2714
(Address of principal executive offices) (Zip Code)
(212) 521-2000
(Registrant’s telephone number, including area code)
NOT APPLICABLE
(Former name, former address and former fiscal year, if changed since last report)
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||
| Common stock, par value $0.01 per share | L | New York Stock Exchange |
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
| Yes | ☒ | No ☐ |
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).
| Yes | ☒ | No ☐ |
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
| Large accelerated filer | ☒ | Accelerated filer | ☐ | Non-accelerated filer | ☐ | Smaller reporting company | ☐ |
| Emerging growth company | ☐ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
| Yes | ☐ | No | ☒ |
As of October 30, 2026, there were 202,225,230 shares of the registrant’s common stock outstanding.
| 1 |
INDEX
| 2 |
PART I. FINANCIAL INFORMATION
Item 1. Financial Statements.
Loews Corporation and Subsidiaries
CONSOLIDATED CONDENSED BALANCE SHEETS
(Unaudited)
| September 30, | December 31, | ||||||||||
| 2026 | 2025 | ||||||||||
| (Dollar amounts in millions, except per share data) | |||||||||||
| Assets: | |||||||||||
| Investments: | |||||||||||
| Fixed maturities, amortized cost of $46,245 and $45,250, less allowance for credit loss of $65 and $69 | $ | 42,301 | $ | 43,984 | |||||||
| Equity securities, cost of $1,282 and $1,201 | 1,284 | 1,292 | |||||||||
| Limited partnership investments | 3,069 | 2,861 | |||||||||
| Other invested assets, primarily mortgage loans, less allowance for credit loss of $15 and $15 | 1,142 | 1,195 | |||||||||
| Short-term investments | 5,715 | 6,044 | |||||||||
| Total investments | 53,511 | 55,376 | |||||||||
| Cash | 505 | 495 | |||||||||
| Receivables | 11,550 | 10,983 | |||||||||
| Property, plant and equipment | 11,016 | 10,695 | |||||||||
| Goodwill | 475 | 349 | |||||||||
| Deferred non-insurance warranty acquisition expenses | 2,868 | 3,220 | |||||||||
| Deferred acquisition costs of insurance subsidiaries | 1,014 | 986 | |||||||||
| Other assets | 4,389 | 4,244 | |||||||||
| Total assets | $ | 85,328 | $ | 86,348 | |||||||
| Liabilities and Equity: | |||||||||||
| Insurance reserves: | |||||||||||
| Claim and claim adjustment expense | $ | 27,917 | $ | 26,599 | |||||||
| Future policy benefits | 12,437 | 13,448 | |||||||||
| Unearned premiums | 7,714 | 7,635 | |||||||||
| Total insurance reserves | 48,068 | 47,682 | |||||||||
| Payable to brokers | 416 | 53 | |||||||||
| Short-term debt | 521 | 1,052 | |||||||||
| Long-term debt | 8,417 | 8,437 | |||||||||
| Deferred income taxes | 550 | 839 | |||||||||
| Deferred non-insurance warranty revenue | 3,626 | 4,138 | |||||||||
| Other liabilities | 4,587 | 4,506 | |||||||||
| Total liabilities | 66,185 | 66,707 | |||||||||
| Commitments and contingent liabilities | |||||||||||
| Preferred stock, $0.10 par value: | |||||||||||
| Authorized – 100,000,000 shares | |||||||||||
| Common stock, $0.01 par value: | |||||||||||
| Authorized – 1,800,000,000 shares | |||||||||||
| Issued – 206,096,908 and 206,003,999 shares | 2 | 2 | |||||||||
| Additional paid-in capital | 2,342 | 2,374 | |||||||||
| Retained earnings | 18,425 | 17,377 | |||||||||
| Accumulated other comprehensive loss | (2,117) | (1,067) | |||||||||
| 18,652 | 18,686 | ||||||||||
| Less treasury stock, at cost (3,244,857 and 0 shares) | (348) | — | |||||||||
| Total shareholders’ equity | 18,304 | 18,686 | |||||||||
| Noncontrolling interests | 839 | 955 | |||||||||
| Total equity | 19,143 | 19,641 | |||||||||
| Total liabilities and equity | $ | 85,328 | $ | 86,348 |
See accompanying Notes to Consolidated Condensed Financial Statements.
| 3 |
Loews Corporation and Subsidiaries
CONSOLIDATED CONDENSED STATEMENTS OF OPERATIONS
(Unaudited)
| Three Months Ended | Nine Months Ended | |||||||||||||||||||||||||
| September 30, | September 30, | |||||||||||||||||||||||||
| 2026 | 2025 | 2026 | 2025 | |||||||||||||||||||||||
| (In millions, except per share data) | ||||||||||||||||||||||||||
| Revenues: | ||||||||||||||||||||||||||
| Insurance premiums | $ | 2,829 | $ | 2,783 | $ | 8,285 | $ | 8,103 | ||||||||||||||||||
| Net investment income | 713 | 743 | 2,087 | 2,065 | ||||||||||||||||||||||
| Investment losses | (9) | (7) | (32) | (62) | ||||||||||||||||||||||
| Non-insurance warranty revenue | 357 | 393 | 1,098 | 1,188 | ||||||||||||||||||||||
| Operating revenues and other | 869 | 759 | 2,610 | 2,426 | ||||||||||||||||||||||
| Total | 4,759 | 4,671 | 14,048 | 13,720 | ||||||||||||||||||||||
| Expenses: | ||||||||||||||||||||||||||
| Insurance claims and policyholders’ benefits (re-measurement loss of $222, $36, $266 and $59) | 2,347 | 2,032 | 6,691 | 6,144 | ||||||||||||||||||||||
| Amortization of deferred acquisition costs | 492 | 483 | 1,449 | 1,423 | ||||||||||||||||||||||
| Non-insurance warranty expense | 339 | 377 | 1,051 | 1,146 | ||||||||||||||||||||||
| Operating expenses and other | 1,090 | 1,000 | 3,139 | 2,980 | ||||||||||||||||||||||
| Equity method income | (16) | (22) | (80) | (39) | ||||||||||||||||||||||
| Interest | 101 | 112 | 317 | 324 | ||||||||||||||||||||||
| Total | 4,353 | 3,982 | 12,567 | 11,978 | ||||||||||||||||||||||
| Income before income tax | 406 | 689 | 1,481 | 1,742 | ||||||||||||||||||||||
| Income tax expense | (84) | (153) | (334) | (398) | ||||||||||||||||||||||
| Net income | 322 | 536 | 1,147 | 1,344 | ||||||||||||||||||||||
| Amounts attributable to noncontrolling interests | (16) | (32) | (60) | (79) | ||||||||||||||||||||||
| Net income attributable to Loews Corporation | $ | 306 | $ | 504 | $ | 1,087 |
Showing the first 8K of 189K characters. Open the full section
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.
Management’s discussion and analysis of financial condition and results of operations (“MD&A”) should be read in conjunction with our Consolidated Condensed Financial Statements included under Item 1 of this Report and the Consolidated Financial Statements, Risk Factors, and MD&A included in our Annual Report on Form 10-K for the year ended December 31, 2025. This MD&A is comprised of the following sections:
OVERVIEW
Loews Corporation is a holding company and has four reportable segments comprised of three individual consolidated operating subsidiaries, CNA Financial Corporation (“CNA”), Boardwalk Pipeline Partners, LP (“Boardwalk Pipelines”) and Loews Hotels Holding Corporation (“Loews Hotels & Co”); and the Corporate segment. The Corporate segment is primarily comprised of Loews Corporation, excluding its consolidated operating subsidiaries, and the equity method of accounting for Altium Packaging LLC (“Altium Packaging”), an unconsolidated subsidiary.
Unless the context otherwise requires, as used herein, the term “Company” means Loews Corporation including its subsidiaries, the terms “Parent Company,” “we,” “our,” “us” or like terms mean Loews Corporation excluding its subsidiaries and the term “Net income (loss) attributable to Loews Corporation” means Net income (loss) attributable to Loews Corporation shareholders.
We rely upon our invested cash balances and distributions from our subsidiaries to generate the funds necessary to meet our obligations and to declare and pay any dividends to our shareholders. The ability of our subsidiaries to pay dividends is subject to, among other things, the availability of sufficient earnings and funds in such subsidiaries, applicable state laws, including in the case of the insurance subsidiaries of CNA, laws and rules governing the payment of dividends by regulated insurance companies (see Note 14 of the Consolidated Financial Statements in our Annual Report on Form 10-K for the year ended December 31, 2025) and compliance with covenants in their respective loan agreements. Claims of creditors of our subsidiaries will generally have priority as to the assets of such subsidiaries over our claims and those of our creditors and shareholders. We are not responsible for the liabilities and obligations of our subsidiaries and there are no Parent Company guarantees.
| 43 |
RESULTS OF OPERATIONS
Consolidated Financial Results
The following table summarizes net income (loss) attributable to Loews Corporation by segment and the basic and diluted net income per share attributable to Loews Corporation for the three and nine months ended September 30, 2026 and 2025:
| Three Months Ended | Nine Months Ended | |||||||||||||||||||
| September 30, | September 30, | |||||||||||||||||||
| 2026 | 2025 | 2026 | 2025 | |||||||||||||||||
| (In millions, except per share data) | ||||||||||||||||||||
| CNA Financial | $ | 180 | $ | 371 | $ | 668 | $ | 897 | ||||||||||||
| Boardwalk Pipelines | 85 | 94 | 344 | 334 | ||||||||||||||||
| Loews Hotels & Co | 16 | (3) | 90 | 25 | ||||||||||||||||
| Corporate | 25 | 42 | (15) | 9 | ||||||||||||||||
| Net income attributable to Loews Corporation | $ | 306 | $ | 504 | $ | 1,087 | $ | 1,265 | ||||||||||||
| Basic and diluted net income per share | $ | 1.50 | $ | 2.43 | $ | 5.29 | $ | 6.03 | ||||||||||||
Net income attributable to Loews Corporation for the three months ended September 30, 2026 was $306 million, or $1.50 per share, compared to net income of $504 million, or $2.43 per share in the comparable 2025 period. Net income attributable to Loews Corporation for the nine months ended September 30, 2026 was $1,087 million, or $5.29 per share, compared to net income of $1,265 million, or $6.03 per share in the comparable 2025 period.
The decrease in net income attributable to Loews Corporation for the three months ended September 30, 2026 as compared to the comparable 2025 period was primarily driven by lower net income at CNA, Boardwalk Pipelines and Corporate, partially offset by higher net income at Loews Hotels & Co. The decrease at CNA is primarily due to an unfavorable impact of $125 million (after-tax and noncontrolling interest) in 2026 from its annual long-term care reserve assumption updates, as well as lower property and casualty underlying underwriting results and higher catastrophe losses. The decrease at Boardwalk Pipelines is primarily due to higher operating expenses, including $14 million (after-tax) of charges related to net unrealized losses at Boardwalk Continuum Marketing, LLC and an impairment charge associated with the relocation of Boardwalk’s corporate office. Excluding those items, results improved year-over-year, benefiting from higher gas transportation revenues. The decrease at Corporate is primarily due to lower investment income from the parent company trading portfolio. The increase at Loews Hotels & Co is primarily due to a higher overall av
Showing the first 8K of 124K characters. Open the full section
Item 3. Quantitative and Qualitative Disclosures about Market Risk.
There were no material changes in our market risk components as of September 30, 2026 from those discussed in the Quantitative and Qualitative Disclosures about Market Risk section included under Item 7A of our Annual Report on Form 10-K for the year ended December 31, 2025. Additional information related to portfolio duration and market conditions is discussed in the Investments section of Management’s Discussion and Analysis of Financial Condition and Results of Operations included under Part I, Item 2.
Item 4. Controls and Procedures.
The Company maintains a system of disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), which is designed to ensure that information required to be disclosed by the Company in reports that it files or submits under the Exchange Act, including this Report, is recorded, processed, summarized and reported on a timely basis. These disclosure controls and procedures include controls and procedures designed to ensure that information required to be disclosed by the Company under the Exchange Act is accumulated and communicated to the Company’s management on a timely basis to allow decisions regarding required disclosure.
The Company’s management, including the Company’s principal executive officer (“CEO”) and principal financial officer (“CFO”) conducted an evaluation of the effectiveness of the Company’s disclosure controls and procedures as of the end of the period covered by this Report and, based on that evaluation, the CEO and CFO concluded that the Company’s disclosure controls and procedures were effective as of September 30, 2026.
There were no changes in the Company’s internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) that occurred during the quarter ended September 30, 2026 that have materially affected or that are reasonably likely to materially affect the Company’s internal control over financial reporting.
PART II. OTHER INFORMATION
Item 1. Legal Proceedings.
Information on our legal proceedings is set forth in Note 11 to the Consolidated Condensed Financial Statements included under Part I, Item 1.
Item 1A. Risk Factors.
Our Annual Report on Form 10-K for the year ended December 31, 2025 includes a discussion of material risk factors facing the Company. There have been no material changes to such risk factors as of the date of this Report.
| 68 |
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.
Items 2 (a) and (b) are inapplicable.
(c) STOCK PURCHASES
| Period | (a) Total number of shares purchased | (b) Average price paid per share | (c) Total number of shares purchased as part of publicly announced plans or programs | (d) Maximum number of shares (or approximate dollar value) of shares that may yet be purchased under the plans or programs (in millions) | |||||||||||||||||||
| July 1, 2026 - July 31, 2026 | N/A | N/A | N/A | N/A | |||||||||||||||||||
| August 1, 2026 - August 31, 2026 | N/A | N/A | N/A | N/A | |||||||||||||||||||
| September 1, 2026 - September 30, 2026 | 1,576,380 | $ | 106.16 | N/A | N/A |
Item 5. Other Information
Item 6. Exhibits.
| Description of Exhibit | Exhibit Number | ||||
| Certification by the Chief Executive Officer of the Company pursuant to Rule 13a-14(a) and Rule 15d-14(a) | 31.1* | ||||
| Certification by the Chief Financial Officer of the Company pursuant to Rule 13a-14(a) and Rule 15d-14(a) | 31.2* | ||||
| Certification by the Chief Executive Officer of the Company pursuant to 18 U.S.C. Section 1350 (as adopted by Section 906 of the Sarbanes-Oxley Act of 2002) | 32.1* | ||||
| Certification by the Chief Financial Officer of the Company pursuant to 18 U.S.C. Section 1350 (as adopted by Section 906 of the Sarbanes-Oxley Act of 2002) | 32.2* | ||||
| XBRL Instance Document – the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document | 101.INS * | ||||
| Inline XBRL Taxonomy Extension Schema | 101.SCH * | ||||
| Inline XBRL Taxonomy Extension Calculation Linkbase | 101.CAL * | ||||
| Inline XBRL Taxonomy Extension Definition Linkbase | 101.DEF * | ||||
| Inline XBRL Taxonomy Label Linkbase | 101.LAB * | ||||
| Inline XBRL Taxonomy Extension Presentation Linkbase | 101.PRE * | ||||
| Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) | 104* |
*Filed herewith.
| 70 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Report to be signed on its behalf by the undersigned, hereunto duly authorized.
| LOEWS CORPORATION | |||||||||||
| (Registrant) | |||||||||||
| Dated: November 2, 2026 | By: | /s/ Jane J. Wang | |||||||||
| JANE J. WANG | |||||||||||
| Senior Vice President and Chief Financial Officer (Duly authorized officer and principal financial officer) |
| 71 |